Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Capital Leases: 2024-2025

Historic Capital Leases for Vanda Pharmaceuticals (VNDA) over the last 1 years, with Sep 2025 value amounting to $2.8 million.

  • Vanda Pharmaceuticals' Capital Leases was N/A to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Capital Leases is $2.8 million, which was down 8.92% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Capital Leases registered a high of $3.1 million during Q4 2024, and its lowest value of $2.8 million during Q3 2025.
  • For the 2-year period, Vanda Pharmaceuticals' Capital Leases averaged around $3.0 million, with its median value being $3.0 million (2025).